Department of Otorhinolaryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, University of Wuerzburg, Wuerzburg, Germany.
Cytotherapy. 2011 Mar;13(3):310-7. doi: 10.3109/14653249.2010.504769. Epub 2010 Aug 26.
The chondrogenic differentiation potential of mesenchymal stromal cells (MSC), as well as their immunosuppressive properties, have been studied extensively. So far, only a few studies have addressed the question of whether MSC still retain their immunosuppressive qualities after transdifferentiation. In particular, the expression of immunogenic markers, such as human leukocyte antigen (HLA)-DR, after differentiation has never been investigated.
Chondrogenic transdifferentiation was induced in human adipose tissue-derived stem cell (ADSC) pellet cultures derived from 10 different patients, using 10 ng/mL transforming growth factor (TGF)-β3. Samples were harvested over a time-course of 28 days and analyzed by immunohistochemistry and reverse transcription (RT)-polymerase chain reaction (PCR). The cytokine levels in the supernatants of the samples were measured semi-quantitatively by dot-blots and quantitatively by enzyme-linked immunosorbant assays (ELISA).
Undifferentiated ADSC were negative for chondrogenic markers, as well as HLA-ABC and HLA-DR epitopes in immunofluorescence. In contrast, TGF-β3-induced pellet cultures showed both expression of chondrogenic differentiation markers, such as transcription factor 9 (Sox 9), collagen type IIa and aggrecan, and an up-regulation of HLA-DR, beginning at day 7 after induction. Interferon-γ (INF-γ) is known to up-regulate HLA-DR. Therefore we measured INF-γ levels in the supernatants of TGF-β3-induced pellets and, indeed, INF-γ was up-regulated during chondrogenesis in ADSC pellet cultures. However, both undifferentiated and TGF-β3-induced ADSC also showed expression of immunosuppressive HLA-G and interleukin (IL)-10 up-regulation.
These results suggest that the immunogenicity of adult stem cell-derived tissue should be tested in animal models before clinical trials for allogeneic engineered tissue are considered.
间充质基质细胞(MSC)的软骨分化潜能及其免疫抑制特性已得到广泛研究。迄今为止,只有少数研究探讨了 MSC 在转分化后是否仍然保留其免疫抑制特性的问题。特别是,分化后免疫原性标志物(如人类白细胞抗原(HLA)-DR)的表达从未被研究过。
使用 10ng/ml 转化生长因子(TGF)-β3 诱导来自 10 位不同患者的人脂肪组织来源的干细胞(ADSC)球培养物的软骨分化。在 28 天的时间过程中采集样本,并通过免疫组织化学和逆转录(RT)-聚合酶链反应(PCR)进行分析。通过斑点印迹和酶联免疫吸附试验(ELISA)定量分析样本上清液中的细胞因子水平。
未分化的 ADSC 在免疫荧光中对软骨标志物以及 HLA-ABC 和 HLA-DR 表位呈阴性。相比之下,TGF-β3 诱导的球培养物在第 7 天诱导后开始表达软骨分化标志物,如转录因子 9(Sox9)、II 型胶原和聚集蛋白,以及 HLA-DR 的上调。干扰素-γ(INF-γ)已知上调 HLA-DR。因此,我们测量了 TGF-β3 诱导的球培养物上清液中的 INF-γ 水平,并且在 ADSC 球培养物的软骨形成过程中确实上调了 INF-γ。然而,未分化和 TGF-β3 诱导的 ADSC 也表现出免疫抑制 HLA-G 和白细胞介素(IL)-10 的上调。
这些结果表明,在考虑进行同种异体工程组织的临床试验之前,应在动物模型中测试成人干细胞来源组织的免疫原性。